The Latest Cardiac and Vascular News
SHANGHAI, Sept. 8, 2022 /PRNewswire/ — Pulnovo Medical Limited, a globally recognized OTM innovative platform, today announced that it has successfully concluded the first Steering Committee meeting for PADN Global Clinical Trial. As members of the Steering Committee, the world’s leading cardiopulmonary experts presented and discussed about the future clinical workflow and the latest […]
The partnership will bring medically supported virtual cardiac rehabilitation and recovery into the homes of patients in Tampa General’s 23-county service area NEW YORK & TAMPA, Fla., Sept. 08, 2022 (GLOBE NEWSWIRE) — Recora today announced that it is partnering with the Tampa General Hospital Heart & Vascular Institute for its Cardiac Recovery Program. […]
HANOVER, Germany–(BUSINESS WIRE)–Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the CE marking of its PCR kit which measures circulating microRNA-132 (miR-132) levels in the blood of patients receiving the company’s lead candidate CDR132L, an oligonucleotide-based miR-132 inhibitor. The company […]
– Study Results Validate the Hypothesis That TTR Silencing by an RNAi Therapeutic has the Potential to be an Effective Approach for Treating Cardiomyopathy of ATTR Amyloidosis – – Patisiran met Primary Endpoint, Demonstrating Significant Clinical Benefit on Functional Capacity (6-MWT) Compared to Placebo at Month 12 – – Patisiran […]
Collaboration will advance the development of compounds designed by Gatehouse Bio’s AI-Powered platform September 08, 2022 08:16 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Gatehouse Bio, a pioneer in small RNA therapeutics, and AstraZeneca, a global, science-led biopharmaceutical company, are advancing their partnership, to create RNA therapeutics for the treatment of heart failure […]
SHANGHAI, Sept. 7, 2022 /PRNewswire/ — A globally recognized OTM innovative platform Pulnovo Medical Limited’s proprietary Pulmonary Artery Denervation (PADN) technology has been included in the 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of pulmonary arterial hypertension (PAH) (hereinafter referred to as “the Guidelines”), jointly issued by the European Society of Cardiology (ESC) […]
Study Evaluates the Effectiveness of TherOx Supersaturated Oxygen (SSO2) Therapy in Patients Presenting with Acute Anterior Myocardial Infarction with Successful Reperfusion Compared to Standard Therapy CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that the first patient has enrolled in […]
– Completed Second Cohort Showed an Average 30% Relative Increase in Ejection Fraction (EF) at 90 Days Following a Single Administration of JK07 – – Cohort 3 Sentinel Subject Demonstrated a >70% Relative EF Increase at Day 30 – – Company also Announces the First CTA Approval for JK08, the First […]
ICOMS FLOWMAKER®, First Fully Implantable Electro-Physiological Cardiac Assistance Device September 07, 2022 08:44 AM Eastern Daylight Time BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER®, a fully Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from severe heart failure, […]
Survey of cardiac rehab clinicians finds that over half started using RPM within just the last two years Campbell, Calif. – September 7, 2022 – Vivalink, a leading provider of digital healthcare solutions, today announces the results of its survey of cardiac rehabilitation clinicians and their insights into the current […]
